MIT Researchers Use AI to Design New Antibiotics for Drug-Resistant Bacteria

Massachusetts Institute of Technology (MIT) researchers have developed novel antibiotics using generative AI to combat drug-resistant bacteria, including MRSA and gonorrhea, announced in a press release. The team designed over 36 million potential compounds, screening them for antimicrobial properties, resulting in structurally distinct antibiotics that disrupt bacterial cell membranes.

The research involved two AI approaches: one focused on designing molecules based on a specific chemical fragment, and the other allowed the AI to generate molecules freely. This led to the discovery of two promising compounds, NG1 and DN1, which showed effectiveness against drug-resistant Neisseria gonorrhoeae and methicillin-resistant Staphylococcus aureus (MRSA) in laboratory and animal tests.

The study, published in the journal Cell, highlights the potential of AI in expanding the chemical space for antibiotic discovery, offering a new strategy to address the growing issue of antibiotic resistance. The research was supported by various organizations, including the U.S. Defense Threat Reduction Agency and the National Institutes of Health.